| Glendora Community Hospital | |
| 150 West Route 66, Glendora, California 91740 | |
| (626) 335-0231 | |
| Name | Glendora Community Hospital |
|---|---|
| Type | Acute Care Hospital |
| Location | 150 West Route 66, Glendora, California |
| Ownership | Proprietary |
| Emergency Services | Yes |
| Medicare ID (CCN) | 050205 |
| NPI Number | 1003807991 |
| Organization Name | EAST VALLEY HOSPITAL MEDICAL CENTER |
| Doing Business As | EAST VALLEY GLENDORA HOSPITAL, L.P. |
| Address | 150 W Route 66, Glendora, CA 91740 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 626-852-5050 |
News Archive
Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
Illumina today announced that on August 1, 2011, its Board of Directors authorized the Company to repurchase, on a discretionary basis, up to $100 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The previous discretionary $100 million share repurchase program authorized in July 2010 was completed this week.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
› Verified 3 days ago
| NPI Number | 1487249298 |
| Organization Name | CHLB, LLC |
| Doing Business As | GLENDORA HOSPITAL |
| Address | 150 W Route 66, Glendora, CA 91740 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 626-852-5015 |
News Archive
Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
Illumina today announced that on August 1, 2011, its Board of Directors authorized the Company to repurchase, on a discretionary basis, up to $100 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The previous discretionary $100 million share repurchase program authorized in July 2010 was completed this week.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
› Verified 3 days ago
| NPI Number | 1649307489 |
| Organization Name | EAST VALLEY GLENDORA HOSPITAL LLC |
| Doing Business As | GLENDORA OAKS BEHAVIORAL HEALTH HOSPITAL |
| Address | 150 W Route 66, Glendora, CA 91740 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 626-852-6125 |
News Archive
Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
Illumina today announced that on August 1, 2011, its Board of Directors authorized the Company to repurchase, on a discretionary basis, up to $100 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The previous discretionary $100 million share repurchase program authorized in July 2010 was completed this week.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
› Verified 3 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Hemispherx Biopharma, Inc., announced that it has received a report, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease, that summarizes the results of a three year Japanese government funded program to develop and test a nasally delivered H5N1 (Avian Flu) vaccine which, when coupled with Ampligen®, an experimental therapeutic, provided a robust and long lasting immune response to the vaccine.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
Illumina today announced that on August 1, 2011, its Board of Directors authorized the Company to repurchase, on a discretionary basis, up to $100 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The previous discretionary $100 million share repurchase program authorized in July 2010 was completed this week.
As part of this year's World Health Day, the WHO on Wednesday will launch a program to encourage cities to become more healthy to help mitigate the health risks associated with rapid urbanization, Agence France Presse/Inquirer.net Global Nation reports.
› Verified 3 days ago
Glendora Community Hospital Acute Care Hospital Location: 150 West Route 66, Glendora, California 91740 Phone: (626) 335-0231 | |
Emanate Health Foothill Presbyterian Hospital Acute Care Hospital Location: 250 S Grand Ave, Glendora, California 91740 Phone: (626) 963-8411 |